Beacon is the No. 1 oncology company of Bangladesh & manufactures latest anticancer drugs……..

While every death from Hepatitis C is a human tragedy millions of people suffer chronic fatigue from the illness, often enduring decades of suffering. Darvoni provides a convenient once a day single tablet formulation containing Sofosbuvir 400 mg + Daclatasvir 60 mg that is suitable to treat all genotypes of Hepatitis C.

In launching Darvoni Beacon Pharma’s goal is to provide an affordable treatment option for HCV delivered to everyone, everywhere all around the globe at a price – $630 USD + Shipping and Handling for a 12 week treatment course – that many will be able to afford.

Darvoni offers the advantages of:

  • Once daily oral single tablet
  • 12 week (84 day) treatment duration for most patients
  • High cure rates ≥ 90 %
  • Effective for all HCV genotypes (pangenotypic)
  • Suitable for patients with cirrhosis and/or co-infection with HIV
  • Indicated for both treatment naive and treatment experienced patients
  • Minimal side effects.

You can find out more about our company at the main Beacon Pharmaceuticals Website. You can find out more about Darvoni here.

And if you would like to be cured of Hepatitis C for less than $1000 USD for the entire treatment (not a single tablet) please submit your details on the order page and one of our representatives will arrange your shipment.